Stock Fundamentals

Company Information

▼
Company Name
Novocure Ltd
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: JE00BYSS4X48
CIK: 0001645113
CUSIP: G6674U108
Currency: USD
Full Time Employees: 1,605
Phone: 44 15 3475 6700
Website: https://www.novocure.com
Fiscal Year End: December
IPO Date: Oct 02, 2015
Description:

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

Address:

Neuhofstrasse 21, Baar, Switzerland, 6340

Directors & Officers

▼
Name Title Year Born
Mr. William F. Doyle Executive Chairman 1962
Mr. Frank Leonard Chief Executive Officer NA
Mr. Barak Ben-Arye General Counsel 1977
Dr. Uri Weinberg M.D., Ph.D. Chief Innovation Officer & Chief Medical Officer 1979
Mr. Christoph Brackmann Chief Financial Officer 1974
Mr. Mukund Paravasthu Chief Operating Officer 1970
Mr. Michael Puri Chief Human Resources Officer 1969

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
FMR Inc 16.80M Dec 31, 2025 14.76% $0.01 0.16%
BlackRock Inc 13.95M Sep 30, 2025 12.26% $0.00 -1.18%
Vanguard Group Inc 10.96M Dec 31, 2025 9.63% $0.00 4.80%
Soleus Capital Management, L.P. 9.64M Sep 30, 2025 8.48% $6.27 39.69%
State Street Corp 2.61M Sep 30, 2025 2.29% $0.00 -2.52%
Geode Capital Management, LLC 2.47M Sep 30, 2025 2.18% $0.00 1.25%
Capital World Investors 2.00M Sep 30, 2025 1.76% $0.00 -68.67%
Quantinno Capital Management LP 1.52M Sep 30, 2025 1.34% $0.05 11.22%
Renaissance Technologies Corp 1.39M Dec 31, 2025 1.22% $0.03 29.35%
Millennium Management LLC 1.34M Sep 30, 2025 1.17% $0.01 106.48%
Nuveen, LLC 1.27M Dec 31, 2025 1.12% $0.00 -25.44%
Palo Alto Investors, LLC 1.26M Sep 30, 2025 1.10% $3.00 30.52%
Jacobs Levy Equity Management, Inc. 1.22M Dec 31, 2025 1.08% $0.06 1,093.17%
UBS Asset Mgmt Americas Inc 1.20M Sep 30, 2025 1.05% $0.00 -12.83%
Baillie Gifford & Co Limited. 1.12M Dec 31, 2025 0.99% $0.01 -0.25%
American Century Companies Inc 1.04M Dec 31, 2025 0.92% $0.01 -14.55%
Marshall Wace Asset Management Ltd 1.03M Sep 30, 2025 0.91% $0.01 -26.84%
Schroder Investment Management Group 1.02M Dec 31, 2025 0.90% $0.01 129.34%
CAM Group Holding A/S 971.78K Sep 30, 2025 0.85% $0.19 56.29%
T. Rowe Price Investment Management,Inc. 945.43K Sep 30, 2025 0.83% $0.01 31.66%

Shares Statistics

▼
Shares Outstanding: 113.79M
Shares Float: 93.88M
% Insiders: 971.80%
% Institutions: 8,605.00%
Short % Float: 12.55%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 FMR Inc 16.80M 14.76% ▲ 0.16% Dec 31, 2025
2 BlackRock Inc 13.95M 12.26% ▼ 1.18% Sep 30, 2025
3 Vanguard Group Inc 10.96M 9.63% ▲ 4.80% Dec 31, 2025
4 Soleus Capital Management, L.P. 9.64M 8.48% ▲ 39.69% Sep 30, 2025
5 State Street Corp 2.61M 2.29% ▼ 2.52% Sep 30, 2025
6 Geode Capital Management, LLC 2.47M 2.18% ▲ 1.25% Sep 30, 2025
7 Capital World Investors 2.00M 1.76% ▼ 68.67% Sep 30, 2025
8 Quantinno Capital Management LP 1.52M 1.34% ▲ 11.22% Sep 30, 2025
9 Renaissance Technologies Corp 1.39M 1.22% ▲ 29.35% Dec 31, 2025
10 Millennium Management LLC 1.34M 1.17% ▲ 106.48% Sep 30, 2025

Valuation Metrics

▼
Enterprise Value: $1.17B
Trailing P/E: 0.00
Forward P/E: 909.09

Financial Highlights

▼
Market Cap: $1.37B
EBITDA: $-135.16M
PEG Ratio: $-0.47
Book Value: $3.03
Earnings/Share: $-1.22
Profit Margin: -20.79%
Operating Margin: -21.33%
ROA (TTM): -9.06%
ROE (TTM): -38.89%
Revenue (TTM): $655.35M
Revenue/Share (TTM): $5.88
Earnings Growth (YOY): -6.00%
Revenue Growth (YOY): 8.10%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 2.90x 0.61x 0.58x -9.03x -1.74x
2024-12-31 1.46x 1.84x 0.71x -14.62x -6.05x
2023-12-31 5.78x 1.80x 0.68x -47.47x -3.68x
2022-12-31 7.00x 1.45x 0.63x -26.85x -8.10x
2021-12-31 7.53x 1.54x 0.64x -12.89x -18.55x
2020-12-31 8.80x 0.92x 0.55x 1.68x 9.73x
2019-12-31 5.10x 0.86x 0.55x -0.07x 24.79x
2018-12-31 4.98x 1.33x 0.67x -2.50x -6.05x
2017-12-31 4.88x 1.72x 0.57x -3.83x -6.17x
2016-12-31 7.10x 1.35x 0.50x -19.42x -1.76x
2015-12-31 10.27x 0.19x 0.18x -43.82x -0.46x
2014-12-31 6.33x 0.01x 0.17x -438.01x -0.01x
2013-12-31 11.76x 0.00x 0.09x -5.09x -0.01x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 05, 2026 Mukund Paravasthu N/A Sale 43.25K $13.77 $595.50K
Mar 04, 2026 Christoph Brackmann N/A Sale 6.41K $13.31 $85.34K
Mar 04, 2026 Frank X Leonard N/A Sale 5.61K $13.31 $74.63K
Mar 04, 2026 Michal Nath Puri N/A Sale 1.10K $13.31 $14.64K
Mar 04, 2026 Mukund Paravasthu N/A Sale 5.38K $13.31 $71.57K
Mar 04, 2026 Uri Weinberg N/A Sale 6.41K $13.31 $85.34K
Mar 03, 2026 William F Doyle N/A Sale 71.89K $12.98 $933.09K
Sep 05, 2025 Ashley Cordova N/A Purchase 81.55K $12.22 $996.54K
Jul 29, 2025 Christoph Brackmann N/A Purchase 20.00K $11.59 $231.80K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NVCR.US!